News

14. Juli 2015

Probiodrug Funds Brigham and Women's Hospital Research into pyroglutamate-Abeta for the Treatment of Alzheimer's Disease

1. Juli 2015

Mandat zum Management der IBG-Fonds in Sachsen-Anhalt geht an die bmp Beteiligungsmanagement AG

29. Mai 2015

Probiodrug to present at the Jefferies Healthcare Conference and BIO International Convention

29. Mai 2015

NOXXON stellt erste Ergebnisse aus klinischer Studie mit NOX-H94 (Lexaptepid Pegol) in ESA-hyporesponsiven Dialysepatienten auf der ERA-EDTA Konferenz vor

12. Mai 2015

Probiodrug to hold its Annual Shareholders Meeting on June 10, 2015 

12. Mai 2015

Probiodrug AG to publish its First Quarter 2015 Business Update on May 13, 2015

12. Mai 2015

Probiodrug to Present at Drug Design & Medicinal Chemistry Conference 2015
GTC 9th Drug Design & Medicinal Chemistry Conference, 5-6 May 2015, Berlin, Germany

24. April 2015

Key patents on Glutaminyl Cyclase (QC) inhibition for the treatment of Alzheimer's disease granted in Japan

Patent grants strengthen IP position in Japan and follow issuance and grants in other important markets such as USA and Europe

24. April 2015

Nature Communications Publications on the First X-ray Crystal Structures of Spiegelmers Bound to Protein Targets
Anti-CCL2 and anti-C5a Spiegelmers Revealed in Complex with Their Targets

31. März 2015

Probiodrug reports full year 2014 financial results

Seiten